Lanzhou Institute of Biological Products Co., Ltd

Works in Hematology · Immunology · Infectious disease · Oncology

Lanzhou Institute of Biological Products Co., Ltd is a clinical trial sponsor. It has 2 active clinical trials with 268 planned participants, in Hematology, Immunology, Infectious disease and Oncology.

Trial track record · since 2021

2Active trials268 planned participants
0Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Pipeline · 2 active trials

StageTrialStatus

Questions about Lanzhou Institute of Biological Products Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-03-03.

Approve Suite is not affiliated with Lanzhou Institute of Biological Products Co., Ltd.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.